AI Business is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Health & Pharma

University of Oxford startup raises $10 million to advance AI in echocardiography

by Chuck Martin
Article ImageUtromics’ first commercial product, EchoGo Core, was approved by the FDA and obtained a CE mark

Ultromics, a startup spun out of the University of Oxford to commercialize AI tech that can read echocardiograms, closed a $10 million financing round to accelerate the growth of its business.

Investors included the Mayo Clinic, which works in collaboration with Ultromics, as well as existing shareholders Oxford Sciences Innovation (OSI) and specialist healthcare investor Nina Capital.

“Mayo Clinic and Nina Capital bring a strong track record and deep expertise in the health-tech sector,” said Ross Upton, CEO and co-founder of Ultromics. “They will help our push into the US market and accelerate the development of new innovations and services.”

Listen to your heart

Ultromic’s first commercial product, EchoGo Core, uses machine learning to analyze echocardiograms in order to help diagnose heart disease. It was approved for use by the US Food and Drug Administration (FDA) in November.

The startup’s more advanced EchoGo Pro, aimed at early detection of heart disease, obtained a CE mark for use in Europe earlier this year, and is pending clearance by the FDA.

Ultromic’s devices can easily plug into hospital systems in use across the US and Europe.

The technology is finding applications related to the ongoing COVID-19 pandemic. Ultromics is working with several US-based clinics, using EchoGo Core to understand how COVID-19 attacks the heart.

The company has also developed a service called Catalyst, to use the EchoGo to accelerate clinical trials.

The AI systems support physicians by automating cardiac analysis, helping provide rapid results to improve care delivery and outcomes.

“Ultromics presents a unique application of artificial intelligence in medical diagnostics in that it is trained on an image of moving anatomy,” Marta-Gaia Zanchi of Nina Capital said.

The seed funding for Ultromics came from current investor OSI, an early-stage investment firm that specializes in fundamental technologies, in partnership with the University of Oxford.

Practitioner Portal - for AI practitioners


UK's ICO publishes guidance on AI and data protection


The document aims to help organizations mitigate the risks of using personal data in AI applications


Perfect AI model, broken app: Integration patterns and testing needs


It is a long way from having a working machine learning model on a local laptop to having a full-fledged fashion store with a mobile app incorporating this model

Practitioner Portal


More EBooks

Upcoming Webinars

More Webinars

Experts in AI

Partner Perspectives

content from our sponsors

Research Reports

More Research Reports


AI tops the list of most impactful emerging technologies

Infographics archive

Newsletter Sign Up

Sign Up